222 related articles for article (PubMed ID: 24413083)
1. Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis.
Heim D; Cornils K; Schulze K; Fehse B; Lohse AW; Brümmendorf TH; Wege H
Oncogene; 2015 Jan; 34(3):364-72. PubMed ID: 24413083
[TBL] [Abstract][Full Text] [Related]
2. Forced activation of β-catenin signaling supports the transformation of hTERT-immortalized human fetal hepatocytes.
Wege H; Heim D; Lütgehetmann M; Dierlamm J; Lohse AW; Brümmendorf TH
Mol Cancer Res; 2011 Sep; 9(9):1222-31. PubMed ID: 21807967
[TBL] [Abstract][Full Text] [Related]
3. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL).
Rajasekaran D; Jariwala N; Mendoza RG; Robertson CL; Akiel MA; Dozmorov M; Fisher PB; Sarkar D
J Biol Chem; 2016 May; 291(20):10736-46. PubMed ID: 26997225
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
[TBL] [Abstract][Full Text] [Related]
6. Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis.
Kou T; Marusawa H; Kinoshita K; Endo Y; Okazaki IM; Ueda Y; Kodama Y; Haga H; Ikai I; Chiba T
Int J Cancer; 2007 Feb; 120(3):469-76. PubMed ID: 17066440
[TBL] [Abstract][Full Text] [Related]
7. A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis.
Angioni MM; Bellofatto K; Merlin S; Menegon S; Perra A; Petrelli A; Sulas P; Giordano S; Columbano A; Follenzi A
Oncotarget; 2017 Feb; 8(9):15716-15731. PubMed ID: 28157710
[TBL] [Abstract][Full Text] [Related]
8. A novel human cancer culture model for the study of prostate cancer.
Yasunaga Y; Nakamura K; Ko D; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Rhim JS
Oncogene; 2001 Nov; 20(55):8036-41. PubMed ID: 11753687
[TBL] [Abstract][Full Text] [Related]
9. Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line.
Jiang W; Wang XW; Unger T; Forgues M; Kim JW; Hussain SP; Bowman E; Spillare EA; Lipsky MM; Meck JM; Cavalli LR; Haddad BR; Harris CC
Int J Cancer; 2010 Sep; 127(5):1011-20. PubMed ID: 20017137
[TBL] [Abstract][Full Text] [Related]
10. Absence of oncogenic transformation despite acquisition of cytogenetic aberrations in long-term cultured telomerase-immortalized human fetal hepatocytes.
Haker B; Fuchs S; Dierlamm J; Brümmendorf TH; Wege H
Cancer Lett; 2007 Oct; 256(1):120-7. PubMed ID: 17630152
[TBL] [Abstract][Full Text] [Related]
11. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
12. Human hepatocyte carcinogenesis (review).
Shiraha H; Yamamoto K; Namba M
Int J Oncol; 2013 Apr; 42(4):1133-8. PubMed ID: 23426905
[TBL] [Abstract][Full Text] [Related]
13. Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.
Petrelli A; Perra A; Schernhuber K; Cargnelutti M; Salvi A; Migliore C; Ghiso E; Benetti A; Barlati S; Ledda-Columbano GM; Portolani N; De Petro G; Columbano A; Giordano S
Oncogene; 2012 Oct; 31(42):4517-26. PubMed ID: 22249248
[TBL] [Abstract][Full Text] [Related]
14. The role of telomeres and telomerase in cirrhosis and liver cancer.
Nault JC; Ningarhari M; Rebouissou S; Zucman-Rossi J
Nat Rev Gastroenterol Hepatol; 2019 Sep; 16(9):544-558. PubMed ID: 31253940
[TBL] [Abstract][Full Text] [Related]
15. Gankyrin Promotes Tumor-Suppressor Protein Degradation to Drive Hepatocyte Proliferation.
D'Souza AM; Jiang Y; Cast A; Valanejad L; Wright M; Lewis K; Kumbaji M; Shah S; Smithrud D; Karns R; Shin S; Timchenko N
Cell Mol Gastroenterol Hepatol; 2018; 6(3):239-255. PubMed ID: 30109252
[TBL] [Abstract][Full Text] [Related]
16. NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.
Macheiner D; Gauglhofer C; Rodgarkia-Dara C; Grusch M; Brachner A; Bichler C; Kandioler D; Sutterlüty H; Mikulits W; Schulte-Hermann R; Grasl-Kraupp B
Cancer Res; 2009 Jan; 69(1):235-42. PubMed ID: 19118008
[TBL] [Abstract][Full Text] [Related]
17. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X protein and c-Myc cooperate in the upregulation of ribosome biogenesis and in cellular transformation.
Shukla SK; Kumar V
FEBS J; 2012 Oct; 279(20):3859-71. PubMed ID: 22889122
[TBL] [Abstract][Full Text] [Related]
19. Serine/threonine kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell.
Gong J; Wang J; Ren K; Liu C; Li B; Shi Y
J Surg Res; 2009 May; 153(1):17-22. PubMed ID: 18675992
[TBL] [Abstract][Full Text] [Related]
20. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.
Zhang J; Lan SJ; Liu QR; Liu JM; Chen XQ
Mol Pharmacol; 2013 May; 83(5):1109-19. PubMed ID: 23478801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]